Академический Документы
Профессиональный Документы
Культура Документы
Components of Hemostasis
5 components
Blood Vessels
Platelets
Coagulation
Fibrinolytic System
Inhibitors of Coagulation
Hemostasis:
BV Injury
Tissue
Factor
Neural
Blood Vessel
Constriction
Platelet
Aggregation
Coagulation
Cascade
Platelet
Activation
Fibrin
formation
Haemostasis
Red blood ce
Platel
Von Willebrand fact
Red blood ce
Platel
Von Willebrand fact
Red blood ce
Platel
Von Willebrand fact
Red blood ce
Platel
Von Willebrand fact
Red blood ce
Platel
Von Willebrand fact
Red blood ce
Platel
Von Willebrand fact
Red blood ce
Platel
Von Willebrand fact
Red blood ce
Platel
Von Willebrand fact
Red blood ce
Platel
Von Willebrand fact
Fibrin polym
Red blood ce
Platel
Von Willebrand fact
Fibrin polym
Red blood ce
Platel
Von Willebrand fact
Fibrin polym
Coagulation cascade
Intrinsic system (surface contact)
XII
XIIa
Tissue factor
XIa
XI
IX
IXa
VIII
VIIa
VIIIa
X
VII
Xa
V
Va
II
Fibrinogen
IIa
(Thrombin)
Fibrin
Coagulation Cascade
Intrinsic Path
(XII,XI,IX,VIII)
Extrinsic Path
(VII)
(aPTT)
(PT)
(Factor X)
Common
Path
(V,II)
(TT)
(Thrombin)
Fibrinogen Fibrin
Platelets
Disorders of Hemostasis
Vascular disorders
Scurvy, easy bruising
Platelet disorders
Low number or abnormal function
Coagulation disorders
Factor deficiency
Mixed/Consumption: DIC
22
Coagulation
Skin
tissue
Mucous membranes
(epistaxis, gum,
vaginal, GI tract)
Deep in soft
Petechiae
Yes
No
Ecchymoses (bruises)
Small, superficial
Large, deep
Extremely rare
Common
Yes
No
Immediate,
usually mild
Delayed (1-2days),
often severe
Site of bleeding
(joints,muscles)
23
Platelet
Petechiae, Ecchymoses
Coagulation
Joint bleeding
24
25
BLEEDING
DISORDERS
Blood vessel
Bleeding time
Bleeding Time
Bleeding time 2-9 minutes
Time taken by a standard skin puncture to stop
bleeding
Prolonged defect in platelet number or function
29
Bleeding Time
Thrombocytopenia
Platelet number
Normal platelet count: 150,000 400,000/uL
> 100,000/uL
Bleeding unlikely
< 20,000/uL
risk for spontaneous
bleeding
Must exclude pseudothrombocytopenia
Etiology of Thrombocytopenia
Decreased Production
Hypoproliferation
Others
Splenic sequestration
Hypersplenism
Dilutional
Thrombocytopen
ia
Giant
platelet
Bernard-Soulier Syndrome
Pseudothrombocytope
nia
ITP
Thrombocytopenia secondary causes are
excluded
destruction of platelets immune
mechanism
Types
Acute - <6mths
Chronic - >6mths
Acute ITP
Most often in children 2 6 yrs
Most often 1 3 wks after viral infection eg; chicken
pox, rubella, CMV, viral hepatitis
Platelet count < 20 x 10 9 / l
Abrupt onset of bleeding
Self limited
Therapy- none
steroids ( severe thrombocytopenia)
Chronic ITP
Adults 20 40 yrs
F: M = 3 : 1
Onset insidious
Antecedent infection unusual
Platelet count 30-60 x 10 9 / l
BT-prolonged
Therapy- Steroids
Splenectomy
Spontaneous remission uncommon
Chronic
Adults 20-45yrs
M:F :: 1:3
-
Onset
Duration
Spontaneous
remission
Suddden
2-8 wks
85-90% cases
Insidious
Months yrs
Rare, need
therapy
Platelet Count
<20,000 usually
30-60,000
Age
Sex
H/o preceeding
viral infection
Pathogenesis
Molecular Mimicry:
VZV
Platelet
MHCII
Macrophage
(APC)
1.
Phagocytosis
MHCII
Macrophage
(APC)
2.
Destruction
1.
Phagocytosis
MHCII
Macrophage
(APC)
APC Activation
2.
Destruction
1.
Phagocytosis
MHCII
Macrophage
(APC)
APC Activation
2.
1.
Destruction
Altered
processing
Phagocytosis
MHCII
Macrophage
(APC)
APC Activation
2.
1.
Destruction
Altered
processing
Phagocytosis
Peptides
3.
Macrophage
(APC)
MHCII
APC Activation
2.
1.
Destruction
Altered
processing
Phagocytosis
Peptides
MHCII
3.
Macrophage
(APC)
4.
Abnormal
Presentation
APC Activation
2.
1.
Destruction
Altered
processing
Phagocytosis
Peptides
CD4+ T cell
Activation
MHCII TcR
3.
Macrophage
(APC)
4.
Abnormal
Presentation
of a platelet
autoantigen
Clinical features
Bleeding into skin, mucous membrane
Menorrhagia adult females
Easy bruising
Intracranial hemorrhage platelet count < 10,000
Splenomegaly & lymphadenopathy rare
Hematological Findings
Platelet count -low
Bone marrow
Megakaryocytic hyperplasia
immature forms+
BT Prolonged
PT & PTT normal
Thrombotic Microangiopathies
Thrombotic Thrombocytopenic Purpura (TTP)
Hemolytic Uremic Syndrome (HUS)
TTP
Fever
Thrombocytopenia
Microangipathic anemia
Renal dysfunction
Seizures
TTP
Endothelial injury bacterial infections
Release of procoagulants & vWF thrombosis
Platelet count 5,000 100,000
PT, APTT-Normal
Platelet transfusion is contraindicated
HUS
Fever
Diarrhea
Microangiopathic HA
Thrombocytopenia
Renal failure
6/17/15
Thrombocytopenia
56
THANK YOU